[癌症分子标志物的未来：迈向个性化治疗] - Suppr

Suppr

超能文献

[The future of molecular markers in cancer: towards a tailored treatment].

作者信息

Gascón Pere

出版信息

Med Clin (Barc). 2009 Apr 18;132(14):549-50. doi: 10.1016/j.medcli.2008.12.019. Epub 2009 Apr 14.

DOI:10.1016/j.medcli.2008.12.019

PMID:19368936

Abstract

摘要

相似文献

[The future of molecular markers in cancer: towards a tailored treatment].

Med Clin (Barc). 2009 Apr 18;132(14):549-50. doi: 10.1016/j.medcli.2008.12.019. Epub 2009 Apr 14.

Proteomics: from signature to protein identification.

J Natl Cancer Inst. 2004 Jun 2;96(11):817. doi: 10.1093/jnci/96.11.817.

Debate rages over proteomic patterns.

J Natl Cancer Inst. 2004 Jun 2;96(11):816-8. doi: 10.1093/jnci/96.11.816.

Biochemical and immunologic diagnosis of cancer. Molecular probes and tumors in general.

Tumour Biol. 1987;8(2-3):166-9.

Soft tissue tumor pathology: New diagnostic immunohistochemical markers.

Semin Diagn Pathol. 2015 Sep;32(5):370-80. doi: 10.1053/j.semdp.2015.02.012. Epub 2015 Feb 4.

[The therapeutic contribution of proteomic approaches in cancers].

Gynecol Obstet Fertil. 2011 Feb;39(2):87-93. doi: 10.1016/j.gyobfe.2010.12.005. Epub 2011 Feb 12.

[Molecular markers having a prognostic or therapeutic value in cancer].

Ann Pathol. 2008 Nov;28 Spec No 1(1):S69-70. doi: 10.1016/j.annpat.2008.09.021. Epub 2008 Oct 15.

The challenges of integrating molecular imaging into the optimization of cancer therapy.

Integr Biol (Camb). 2011 Jun;3(6):603-31. doi: 10.1039/c0ib00131g. Epub 2011 May 4.

IMP3: a new and important biomarker of systemic malignancies.

Clin Cancer Res. 2008 Sep 1;14(17):5640; author reply 5640-1. doi: 10.1158/1078-0432.CCR-08-0813.

Minichromosome maintenance proteins in cancer screening.

Eur J Cancer. 2009 Sep;45 Suppl 1:416-7. doi: 10.1016/S0959-8049(09)70071-1.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

[The future of molecular markers in cancer: towards a tailored treatment].

Med Clin (Barc). 2009 Apr 18;132(14):549-50. doi: 10.1016/j.medcli.2008.12.019. Epub 2009 Apr 14.

Proteomics: from signature to protein identification.

J Natl Cancer Inst. 2004 Jun 2;96(11):817. doi: 10.1093/jnci/96.11.817.

Debate rages over proteomic patterns.

J Natl Cancer Inst. 2004 Jun 2;96(11):816-8. doi: 10.1093/jnci/96.11.816.

Biochemical and immunologic diagnosis of cancer. Molecular probes and tumors in general.

Tumour Biol. 1987;8(2-3):166-9.

Soft tissue tumor pathology: New diagnostic immunohistochemical markers.

Semin Diagn Pathol. 2015 Sep;32(5):370-80. doi: 10.1053/j.semdp.2015.02.012. Epub 2015 Feb 4.

[The therapeutic contribution of proteomic approaches in cancers].

Gynecol Obstet Fertil. 2011 Feb;39(2):87-93. doi: 10.1016/j.gyobfe.2010.12.005. Epub 2011 Feb 12.

[Molecular markers having a prognostic or therapeutic value in cancer].

Ann Pathol. 2008 Nov;28 Spec No 1(1):S69-70. doi: 10.1016/j.annpat.2008.09.021. Epub 2008 Oct 15.

The challenges of integrating molecular imaging into the optimization of cancer therapy.

Integr Biol (Camb). 2011 Jun;3(6):603-31. doi: 10.1039/c0ib00131g. Epub 2011 May 4.

IMP3: a new and important biomarker of systemic malignancies.

Clin Cancer Res. 2008 Sep 1;14(17):5640; author reply 5640-1. doi: 10.1158/1078-0432.CCR-08-0813.

Minichromosome maintenance proteins in cancer screening.

Eur J Cancer. 2009 Sep;45 Suppl 1:416-7. doi: 10.1016/S0959-8049(09)70071-1.